Featured Research

from universities, journals, and other organizations

First National Zinc Campaign For Childhood Diarrhea Increases Awareness, But Use Lags Behind

Date:
November 2, 2009
Source:
Public Library of Science
Summary:
In a study assessing the impact of the first national campaign to scale up zinc treatment of diarrhea in Bangladesh, researchers found that awareness was high but usage lagged behind.

In a study assessing the impact of the first national campaign to scale up zinc treatment of diarrhea in Bangladesh, researchers found that awareness was high but usage lagged behind. In this week's open access journal PLoS Medicine, Charles Larson and colleagues from International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) report the results of seven repeated ecologic surveys in four areas in Bangladesh, representing 1.5 million children under the age of 5.

Related Articles


The researchers found that awareness was less than 10% in all communities pre-launch and peaked 10 months later at 90, 74, 66 and 50% in urban non-slum, municipal, urban slum, and rural sites, respectively. After 23 months 25% of urban non-slum, 20% of municipal and urban slum, and 10% of rural children under 5 years were actually receiving zinc for childhood diarrhea. Use of zinc was found to be safe, with few side-effects, and did not affect the use of traditional treatments for diarrhea. The researchers also found that many children were not given the correct 10-day course of treatment: 50% of parents were sold seven or fewer zinc tablets.

The ''Scaling Up of Zinc for Young Children'' (SUZY) project, funded by the Bill & Melinda Gates Foundation, was established in 2003 to develop a scale-up campaign, produce and distribute zinc tablets, train health professionals to provide zinc treatment, and create media campaigns (such as adverts in TV, radio, and newspapers) to raise awareness and promote the use of zinc for diarrhea.

Diarrheal disease is a significant global health problem causing about 4 billion cases and 2.5 million deaths annually, and disproportionately affecting those in the developing world. Clinical trials show that zinc can help reduce the severity and duration of diarrhea as well as lower the likelihood of a repeat episode in the future. Zinc is now included in the guidelines by the World Health Organization (WHO)/UNICEF for treatment of childhood diarrhea.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Larson CP, Saha UR, Nazrul H. Impact Monitoring of the National Scale Up of Zinc Treatment for Childhood Diarrhea in Bangladesh: Repeat Ecologic Surveys. PLoS Medicine, 2009; 6 (11): e1000175 DOI: 10.1371/journal.pmed.1000175

Cite This Page:

Public Library of Science. "First National Zinc Campaign For Childhood Diarrhea Increases Awareness, But Use Lags Behind." ScienceDaily. ScienceDaily, 2 November 2009. <www.sciencedaily.com/releases/2009/11/091102204431.htm>.
Public Library of Science. (2009, November 2). First National Zinc Campaign For Childhood Diarrhea Increases Awareness, But Use Lags Behind. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2009/11/091102204431.htm
Public Library of Science. "First National Zinc Campaign For Childhood Diarrhea Increases Awareness, But Use Lags Behind." ScienceDaily. www.sciencedaily.com/releases/2009/11/091102204431.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins